LivaNova PLC (LIVN) stock
LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3021% above fair value
$94.54+2.62 (+2.85%)
Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –
LivaNova cash
Cash and short-term investments held at the end of each period.
LivaNova's cash was $516.62M at Jun 30, 2026. For fiscal 2025 it was $635.55M, down 12.2% from the year before. Over ten years it grew 17.7% a year on average. The highest annual figure on record is $723.56M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $635.55M | -12.2% |
| FY2024 | Dec 31, 2024 | $723.56M | +171.5% |
| FY2023 | Dec 31, 2023 | $266.50M | -48.3% |
| FY2022 | Dec 31, 2022 | $515.62M | +147.9% |
| FY2021 | Dec 31, 2021 | $207.99M | -17.7% |
| FY2020 | Dec 31, 2020 | $252.83M | +313.5% |
| FY2019 | Dec 31, 2019 | $61.14M | +29.5% |
| FY2018 | Dec 31, 2018 | $47.20M | -49.6% |
| FY2017 | Dec 31, 2017 | $93.62M | -24.6% |
| FY2015 | Apr 24, 2015 | $124.19M | 0.0% |
| FY2014 | Apr 25, 2014 | $124.19M | +20.2% |
| FY2013 | Apr 26, 2013 | $103.30M | +6.9% |
| FY2012 | Apr 27, 2012 | $96.66M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $516.62M | -13.0% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $539.71M | -26.9% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $635.55M | -12.2% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $646.08M | -3.1% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $593.64M | -6.2% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $738.44M | +19.9% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $723.56M | +171.5% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $666.58M | +25.1% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $633.12M | +18.5% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $615.68M | +17.7% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $266.50M | -48.3% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $532.72M | +5.2% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $534.36M | +31.4% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $522.96M | +18.2% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $515.62M | +147.9% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $506.28M | +178.4% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $406.77M | +23.5% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $442.38M | +75.2% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $207.99M | -17.7% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $181.85M | -20.2% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $329.39M | +41.6% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $252.54M | +100.7% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $252.83M | +313.5% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $227.81M | +202.5% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $232.55M | +422.5% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $125.82M | +147.8% |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | $61.14M | +29.5% |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | $75.31M | -5.8% |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | $44.51M | -6.1% |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | $50.78M | -21.8% |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | $47.20M | -49.6% |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $79.95M | +22.7% |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $47.38M | +11.0% |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | $64.96M | +3.6% |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $93.62M | -24.6% |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | $65.16M | -43.9% |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | $42.69M | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | $62.72M | – |
| Q4 FY2015CQ1 2015 | Apr 24, 2015 | $124.19M | – |
| Q3 FY2015CQ4 2014 | Jan 23, 2015 | $116.22M | – |
See a number that looks wrong?